BNP PARIBAS ARBITRAGE, SA

Position in ACIU — AC Immune SA

CIK 1166588 NEW YORK, NY

Position in ACIU

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$6,627

-$1,160 QoQ

Shares Held

2,410

-2.8% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2021

14 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

BNP PARIBAS ARBITRAGE, SA holds $2,945,837,016 across 415 Biotechnology names. ACIU ranks #312 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	448,371	$346,429,369
2	MRNA	Moderna, Inc.	4,317,219	$219,314,725
3	VRTX	Vertex Pharmaceuticals Inc / Ma	415,625	$185,593,187
4	BNTX	BioNTech SE	1,651,789	$146,811,006
5	ARGX	Argenx SE	177,836	$129,864,739
6	INSM	INSMED Inc	604,600	$98,864,192
7	BBIO	BridgeBio Pharma, Inc.	1,307,176	$97,070,889
8	ALNY	Alnylam Pharmaceuticals, Inc.	280,965	$92,962,889

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$6,627	2,410	-2.8%	Shares	Defined	2026-05-12
2025-12-31	$7,787	2,480	-11.5%	Shares	Defined	2026-02-10
2025-09-30	$8,100	2,803	+111.2%	Shares	Defined	2025-11-13
2025-06-30	$2,693	1,327	+9.6%	Shares	Defined	2025-08-14
2025-03-31	$2,264	1,211	-39.5%	Shares	Defined	2025-05-14
2024-12-31	$5,408	2,003	-11.6%	Shares	Defined	2025-02-14
2024-09-30	$8,561	2,265	-36.4%	Shares	Defined	2024-11-13
2024-06-30	$14,220	3,564	-67.9%	Shares	Defined	2024-08-13
2024-03-31	$32,832	11,092	+315.6%	Shares	Defined	2024-05-01
2023-12-31	$13,345	2,669	+196.2%	Shares	Defined	2024-02-14
2022-12-31	$1,838	901	+13.6%	Shares	Defined	2023-02-14
2022-09-30	$2,505	793	-72.4%	Shares	Defined	2022-11-16
2022-06-30	$10,357	2,869	-79.0%	Shares	Defined	2022-08-12
2021-09-30	$91,537	13,642	—	Shares	Defined	2021-11-16
No filing history on record for this holder in this stock.